Skip to Main Content

Paper Details

Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.
Eur J Cancer
3
2023
Author NameAffiliation
Nam D TranH. Lee Moffitt Cancer Center & Research Institute
Michael A VogelbaumH. Lee Moffitt Cancer Center & Research Institute
  • 1 - 2

Datasets

Release 1.2